Avoli M, Barbarosie M, Lücke A, Nagao T, Lopantsev V, Köhling R
Montreal Neurological Institute, McGill University, Quebec, Canada.
J Neurosci. 1996 Jun 15;16(12):3912-24. doi: 10.1523/JNEUROSCI.16-12-03912.1996.
Application of 4-aminopyridine (4AP, 50 microM) to combined slices of adult rat hippocampus-entorhinal cortex-induced ictal and interictal epileptiform discharges, as well as slow field potentials that were abolished by the mu-opioid agonist [D-Ala2,N-Me-Phe4,Gly-ol5] enkephalin (DAGO, 10 microM) or the GABAA receptor antagonist bicuculline methiodide (BMI, 10 microM); hence, they represented synchronous GABA-mediated potentials. Ictal discharges originated in the entorhinal cortex and propagated to the hippocampus, whereas interictal activity of CA3 origin was usually recorded in the hippocampus. The GABA-mediated potentials had no fixed site of origin or modality of propagation; they closely preceded (0.2-5 sec) and thus appeared to initiate ictal discharges. Only ictal discharges were blocked by the antagonist of the NMDA receptor 3,3-(2-carboxypiperazine-4-yl)propyl-1-phosphonate (CPP, 10 microM), whereas the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 microM) abolished all epileptiform activities. The GABA-mediated potentials continued to occur synchronously in all regions even after concomitant application of CNQX and CPP. [K+]o elevations were recorded in the entorhinal cortex during the ictal discharge (peak values = 13.9 +/- 0.9 mM) and the synchronous GABA-mediated potentials (peak values = 4.2 +/- 0.1 mM); the latter increases were presumably attributable to postsynaptic GABAa-receptor activation because they were abolished by DAGO or BMI. Their role in initiating ictal activity was demonstrated by using DAGO, which abolished both GABA-mediated synchronous potentials and ictal discharges. These data indicate that NMDA-mediated ictal discharges induced by 4AP originate in the entorhinal cortex; such a conclusion is in line with clinical evidence obtained in temporal lobe epilepsy patients. 4AP also induces GABA-mediated potentials that spread within the limbic system when excitatory transmission is blocked and may play a role in initiating ictal discharge by increasing [K+]o.
将4-氨基吡啶(4AP,50微摩尔)应用于成年大鼠海马-内嗅皮质联合切片,可诱发发作期和发作间期癫痫样放电,以及慢场电位,这些电位可被μ-阿片受体激动剂[D-Ala2,N-Me-Phe4,Gly-ol5]脑啡肽(DAGO,10微摩尔)或GABAA受体拮抗剂荷包牡丹碱甲碘化物(BMI,10微摩尔)消除;因此,它们代表同步的GABA介导的电位。发作期放电起源于内嗅皮质并传播至海马,而起源于CA3的发作间期活动通常记录于海马。GABA介导的电位没有固定的起源部位或传播方式;它们在发作期放电之前不久(0.2 - 5秒)出现,因此似乎引发了发作期放电。只有发作期放电被NMDA受体拮抗剂3,3-(2-羧基哌嗪-4-基)丙基-1-膦酸(CPP,10微摩尔)阻断,而非NMDA受体拮抗剂6-氰基-7-硝基喹喔啉-2,3-二酮(CNQX,10微摩尔)消除了所有癫痫样活动。即使同时应用CNQX和CPP后,GABA介导的电位仍在所有区域同步出现。在发作期放电期间(峰值 = 13.9 ± 0.9毫摩尔)和同步的GABA介导的电位期间(峰值 = 4.2 ± 0.1毫摩尔),在内嗅皮质记录到[K+]o升高;后者的升高可能归因于突触后GABAa受体激活,因为它们被DAGO或BMI消除。使用DAGO证明了它们在引发发作期活动中的作用,DAGO消除了GABA介导的同步电位和发作期放电。这些数据表明,4AP诱导的NMDA介导的发作期放电起源于内嗅皮质;这一结论与颞叶癫痫患者获得的临床证据一致。当兴奋性传递被阻断时,4AP还诱导GABA介导的电位在边缘系统内传播,并可能通过增加[K+]o在引发发作期放电中起作用。